Technical Analysis for NPHC - Nutra Pharma Corp

Grade Last Price % Change Price Change
grade F 0.0002 0.00% 0.0000
NPHC closed unchanged on Friday, October 18, 2019, on 20 percent of normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical NPHC trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%

Older signals for NPHC ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Nutra Pharma Corp. is a biopharmaceutical company. The Company is engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies, as well as homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, autoimmune and infectious diseases. The Company's subsidiary and drug discovery arm, ReceptoPharm, Inc. (ReceptoPharm), carries its homeopathic and drug discovery research and clinical development and has developed homeopathic drugs for the treatment of pain: Cobroxin, an over-the-counter pain reliever designed to treat moderate to severe (Stage II) chronic pain; Nyloxin and Nyloxin Extra Strength, stronger versions of Cobroxin, and Pet Pain-Away, an over-the-counter pain reliever designed to treat pain in cats and dogs. It has developed two drug candidates: RPI-78M, to treat neurological diseases and autoimmune diseases, and RPI-MN, to treat viral diseases.
Medicine Health Cancer Pharmaceutical Industry Biopharmaceutical Pain Medication Pharmaceutical Products Drug Discovery Autoimmune Diseases Chronic Pain Neurological Disorders Autoimmunity Drug Pseudoscience Homeopathy Viral Diseases Autoimmune And Infectious Diseases
Is NPHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.0006
52 Week Low 0.0002
Average Volume 3,771,179
200-Day Moving Average 0.0003
50-Day Moving Average 0.0003
20-Day Moving Average 0.0003
10-Day Moving Average 0.0002
Average True Range 0.0007
ADX 2.22
+DI 87.5
-DI 87.5
Chandelier Exit (Long, 3 ATRs ) -0.0017
Chandelier Exit (Short, 3 ATRs ) 0.0023
Upper Bollinger Band 0.0004
Lower Bollinger Band 0.0002
Percent B (%b) 0.0
BandWidth 66.666667
MACD Line -0.0003
MACD Signal Line -0.0001
MACD Histogram -0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0004
Resistance 3 (R3) 0.0004 0.0003 0.0003
Resistance 2 (R2) 0.0003 0.0003 0.0003 0.0003
Resistance 1 (R1) 0.0003 0.0003 0.0003 0.0003 0.0003
Pivot Point 0.0002 0.0002 0.0002 0.0002 0.0002
Support 1 (S1) 0.0002 0.0002 0.0002 0.0002 0.0001
Support 2 (S2) 0.0001 0.0002 0.0001 0.0001
Support 3 (S3) 0.0001 0.0001 0.0001
Support 4 (S4) 0.0001